TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2014

Phase I/II study of the antibody-drug conjugate glembatumumab vedotin in patients with advanced melanoma.

Patrick A Ott et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.